Literature DB >> 12660253

Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome. An aggressive, but perhaps life-saving procedure.

Z O Amarin1.   

Abstract

Two case histories are described, in which protracted courses of severe ovarian hyperstimulation syndrome (OHSS) responded poorly to conservative treatment. Each patient underwent bilateral partial oophorectomy at 14 and 16 days respectively, post oocyte retrieval. Serum albumin levels returned to normal within three days of the operation in each case and the patients, one pregnant with twins, made a rapid recovery. This seemingly 'aggressive' procedure is proposed as a potentially useful treatment when faced with patients who are severely or critically affected with OHSS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660253     DOI: 10.1093/humrep/deg116

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

1.  Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction.

Authors:  Vinita Sherwal; Sonia Malik; Vandana Bhatia
Journal:  J Hum Reprod Sci       Date:  2010-05

2.  Ovarian hyperstimulation syndrome in a spontaneous pregnancy with invasive mole: report of a case.

Authors:  Myriam Rachad; Hikmat Chaara; Fatim Zahra Fdili; Hakima Bouguern; Abdilah Melhouf
Journal:  Pan Afr Med J       Date:  2011-06-27

3.  Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome.

Authors:  Shohreh Movahedi; Leili Safdarian; Marzieh Agahoseini; Ashraf Aleyasin; Sepideh Khodaverdi; Sara Asadollah; Ali Kord Valeshabad; Parvin Fallahi; Zahra Rezaeeian
Journal:  Med J Islam Repub Iran       Date:  2016-05-17

4.  Management of severe ovarian hyperstimulation syndrome with thawed plasma.

Authors:  Mohan S Kamath; Asmita Joshi; Anne Marie Kamath; Tk Aleyamma
Journal:  J Hum Reprod Sci       Date:  2013-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.